Sunday, 17 October 2021

 

 

 

Covishield will be commercialised once trials are successful : Serum Institute of India

Web Admin

Web Admin

5 Dariya News

New Delhi , 23 Aug 2020

Serum Institute of India, has clarified that the current claims surrounding Covishield's availability in the media are completely false and conjectural."Presently, the government has granted us permission to only manufacture the vaccine and stockpile it for future use", SII said in a statement."Covishield will be commercialised once the trials are proven successful and all the requisite regulatory approvals are in place", it added."The phase-3 trials for the Oxford-AstraZeneca vaccine are still underway. And only once the vaccine is proven immunogenic and efficacious, SII will confirm its availability, officially", the statement said."Serum Institute of India, would like to clarify that the current claims surrounding Covishield's availability in the media are completely false and conjectural", it said.The clarification came after reports that the vaccine would get commercialized in 73 days.

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , India Fights Corona , Fight Against Corona , Stay Home Stay Safe , Stay Home , Corona Virus Updates , Coronavirus Epidemic , Coronavirus Pandemic , Corona virus threat , Corona Outbreak , Serum Institute of India , Covishield

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2021 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD